“Interleukin-6 production,” which promotes DLBCL migration by activating the migration mechanism driven by JAK-STAT, was enriched in DCLBCs at multiple primary sites [30–32]. The gene discussed is IL6; the disease is diffuse large B-cell lymphoma.